Fundacion Sanatorio Guemes

CABA, Buenos Aires C1180AAX

0 studies enrolling now · 2 studies all time

What they study most

COVID-19, Type 2 Diabetes Mellitus

Studies at this site

• A Phase 2 Study of LY3209590 in Participants With Type 2 Diabetes Mellitus — Completed
• A Study of Baricitinib (LY3009104) in Participants With COVID-19 — Completed